乐心医疗
(300562)
| 流通市值：21.66亿 | | | 总市值：29.05亿 |
| 流通股本：1.63亿 | | | 总股本：2.19亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 283,737,915.92 | 986,210,596.57 | 757,129,146.52 | 521,364,786.34 |
| 营业收入 | 283,737,915.92 | 986,210,596.57 | 757,129,146.52 | 521,364,786.34 |
| 二、营业总成本 | 250,558,737.99 | 886,886,005.21 | 685,490,345.42 | 470,355,356.57 |
| 营业成本 | 176,584,878.54 | 635,079,142.63 | 487,684,162.71 | 338,865,245.07 |
| 税金及附加 | 1,886,539.74 | 8,961,737.42 | 5,270,907 | 3,976,047.66 |
| 销售费用 | 18,027,854 | 77,018,249.79 | 62,173,571.68 | 42,311,401.59 |
| 管理费用 | 23,090,151.1 | 69,639,875.89 | 58,034,995.18 | 36,329,402.08 |
| 研发费用 | 26,686,069.37 | 95,104,108.21 | 70,314,459.02 | 49,957,539.37 |
| 财务费用 | 4,283,245.24 | 1,082,891.27 | 2,012,249.83 | -1,084,279.2 |
| 其中:利息费用 | 37,015.86 | 2,355,028.19 | 3,002,999.71 | 1,598,440.73 |
| 其中:利息收入 | 330,331.38 | 6,635,100.25 | 4,886,259.94 | 2,703,077.82 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,187,919.68 | 429,539.63 | -137,329.82 | 194,305.79 |
| 加:投资收益 | -75,604.92 | 4,786,295.35 | 4,331,584.38 | 3,123,644.26 |
| 资产处置收益 | 53,996.28 | -26,109.1 | -2,769.11 | -150,131.33 |
| 资产减值损失(新) | - | -21,056,488.12 | -5,755,914.8 | -5,714,429.83 |
| 信用减值损失(新) | -2,195,383.67 | -2,646,254.78 | -4,969,898.63 | -5,939,668.22 |
| 其他收益 | 695,479.09 | 5,515,283.56 | 3,321,716.79 | 1,555,731.01 |
| 四、营业利润 | 32,845,584.39 | 86,326,857.9 | 68,426,189.91 | 44,078,881.45 |
| 加:营业外收入 | 43,164.8 | 214,999.78 | 144,782.49 | 109,459.32 |
| 减:营业外支出 | 65,590.33 | 2,196,122.07 | 816,197.34 | 62,951.95 |
| 五、利润总额 | 32,823,158.86 | 84,345,735.61 | 67,754,775.06 | 44,125,388.82 |
| 减:所得税费用 | 931,104.49 | 4,076,953.51 | 2,992,615.73 | 2,874,102.54 |
| 六、净利润 | 31,892,054.37 | 80,268,782.1 | 64,762,159.33 | 41,251,286.28 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 31,892,054.37 | 80,268,782.1 | 64,762,159.33 | 41,251,286.28 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 32,073,808.31 | 81,999,096.6 | 65,681,388.28 | 42,290,430.52 |
| 少数股东损益 | -181,753.94 | -1,730,314.5 | -919,228.95 | -1,039,144.24 |
| 扣除非经常损益后的净利润 | 31,357,459.02 | 76,802,074.54 | 59,617,527.59 | 38,070,928.81 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.15 | 0.38 | 0.3 | 0.19 |
| (二)稀释每股收益 | 0.15 | 0.38 | 0.3 | 0.19 |
| 八、其他综合收益 | -6,631.94 | -12,668,222.99 | -723,961.64 | -812,328.02 |
| 归属于母公司股东的其他综合收益 | -6,631.94 | -12,668,222.99 | -723,961.64 | -812,328.02 |
| 九、综合收益总额 | 31,885,422.43 | 67,600,559.11 | 64,038,197.69 | 40,438,958.26 |
| 归属于母公司股东的综合收益总额 | 32,067,176.37 | 69,330,873.61 | 64,957,426.64 | 41,478,102.5 |
| 归属于少数股东的综合收益总额 | -181,753.94 | -1,730,314.5 | -919,228.95 | -1,039,144.24 |
| 公告日期 | 2026-04-24 | 2026-04-10 | 2025-10-28 | 2025-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |